logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Edenbridge Pharmaceuticals Names Douglas S. Boothe As CEO

Dec 20, 2023•almost 2 years ago

Position

Chief Executive Officer

Company

Edenbridge Pharmaceuticals

Douglas S. Boothe
ParsippanyPharmaceutical Manufacturing

Description

Edenbridge Pharmaceuticals, the U.S. subsidiary of Dexcel Pharma, today announced that Douglas S. Boothe has been named Chief Executive Officer, effective January 1, 2024

Company Information

Company

Edenbridge Pharmaceuticals

Location

Parsippany, New Jersey, United States

About

Edenbridge Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products. Our goal is to create a broad portfolio of limited source branded and generic pharmaceutical products that will provide high-quality, affordable, and accessible alternatives in the healthcare market. Our approach is to work with best-in-class and like-minded industry partners to deliver our products to physicians and patients everywhere.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months